Peter Mueller, Director at BioXcel Therapeutics, Inc. (BTAI), bought 4,007 shares at $5.11 ($21K) on 2018-12-04, disclosed to the SEC on 2018-12-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.09 | 1,076 | $5K | 26.7% |
| 2 | $5.11 | 325 | $2K | 8.1% |
| 3 | $5.12 | 344 | $2K | 8.6% |
| 4 | $5.13 | 200 | $1K | 5.0% |
| 5 | $5.15 | 2,062 | $11K | 51.7% |
| Total | $5.13 avg | 4,007 |
| $21K |
| 100% |
| Filing → |
| BTAI | BUY | 2018-12-07 | $44K | — | Filing → |
| VRTX | SELL | 2014-06-18 | $512K | — | Filing → |
| VRTX | SELL | 2014-05-16 | $506K | — | Filing → |